Tilray France

Paris, FranceFounded 2021

Medical & Pharma NASDAQ: TLRY tilray.com

Share:X / Twitter LinkedIn Suggest a correction

About Tilray France

Tilray France is the French operations division of Canadian cannabis giant Tilray, participating in France's medical cannabis pilot program launched in 2021.

Key Facts

1Selected as a supplier for France's medical cannabis experimentation program
2Part of Tilray Brands, one of the world's largest cannabis companies

Latest News

Cannabis Stocks Rally as DEA Moves Marijuana to Schedule III

4d ago

AKAN surges alongside TLRY and CGC as federal rescheduling triggers sector-wide momentum with June 2026 hearing set to finalize broader cannabis reclassification.

Major Cannabis Stocks Plunge on Rescheduling Reality Check

5d ago

TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.

Cannabis Stocks Plunge as Rescheduling Optimism Fades

5d ago

Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.

TLRY Stock Plunges 19% as Cannabis Sector Faces Mounting Pressure

5d ago

Tilray Brands shares tumble amid broader cannabis market selloff, raising questions about sector fundamentals and investor appetite for marijuana stocks.

Cannabis Stocks Whipsaw on Federal Rescheduling Uncertainty

5d ago

TLRY and cannabis equities experience volatile trading as investors parse mixed signals on federal marijuana policy changes and regulatory timeline.

View all TLRY news

Frequently Asked Questions

Is medical cannabis legal in France?

France launched a medical cannabis pilot program in 2021, allowing select patients to access cannabis-based treatments through authorized suppliers like Tilray.